Oxford BioMedica's market cap is currently £728.05M. The company's EPS TTM is p; its P/E ratio is -17.28; Oxford BioMedica is scheduled to report earnings on September 23, 2025, and the estimated EPS forecast is p-0.20. See an overview of income statement, balance sheet, and cash flow financials.
